Related Experiment Video
Updated: Jul 16, 2026
08:42
Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
Published on: July 3, 2020
The Genetics of PPARG and the Skeleton
Cheryl Ackert-Bicknell1, Clifford Rosen
1The Jackson Laboratory, Bar Harbor ME 04609, USA.
PPAR Research
|March 10, 2007
Summary
Peroxisome proliferator-activated receptor gamma (PPARG) influences bone health. Genetic variations in PPARG may affect bone mineral density and fracture risk, but further research is needed to clarify these associations in humans.
Area of Science:
- Bone biology and genetics
- Metabolic bone disorders
Background:
- Osteoporosis is a metabolic bone disorder characterized by impaired bone formation.
- The role of "obesity in bone" and its impact on bone formation is increasingly recognized.
- Peroxisome proliferator-activated receptor gamma (PPARG) is implicated in bone metabolism, with mouse models showing altered bone formation.
Purpose of the Study:
- To investigate the association between PPARG genetic polymorphisms and skeletal phenotypes in humans.
- To examine the impact of PPARG variations on bone mineral density (BMD) and fracture risk.
- To clarify the genetic contribution of PPARG to osteoporosis.
Main Methods:
- Review of existing genetic studies on PPARG polymorphisms and skeletal phenotypes.
- Analysis of associations between specific PPARG polymorphisms (e.g., Pro12Ala) and human skeletal traits.
- Correlation of genetic findings with bone mineral density (BMD) and fracture risk data.
Main Results:
- Previous studies suggest a link between a missense polymorphism in exon one of PPARG and low BMD.
- The most widely studied polymorphism, Pro12Ala, has not been adequately examined in relation to skeletal phenotypes.
- Current genetic evidence for PPARG's role in human skeletal phenotypes remains inconclusive.
Conclusions:
- PPARG is a potential genetic factor influencing bone metabolism and osteoporosis risk.
- Further research is required to elucidate the specific role of PPARG polymorphisms, particularly Pro12Ala, in human BMD and fracture risk.
- Understanding the genetic contribution of PPARG is crucial for advancing osteoporosis research.
Related Concept Videos
01:17Hormones and Bone Tissue
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
02:41Lethal Alleles
Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
01:33Pleiotropy
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
01:40Bone Remodeling
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
01:09Changes in the Appendicular Skeleton with Age
The upper and lower limb initially develops as a small bulge called a limb bud, which appears on the lateral side of the early embryo. The upper limb bud appears near the end of the fourth week of development, with the lower limb bud appearing shortly after.
Initially, the limb buds consist of a core of mesenchyme covered by a layer of ectoderm. The ectoderm at the end of the limb bud thickens to form a narrow crest called the apical ectodermal ridge. This ridge stimulates the underlying...
Initially, the limb buds consist of a core of mesenchyme covered by a layer of ectoderm. The ectoderm at the end of the limb bud thickens to form a narrow crest called the apical ectodermal ridge. This ridge stimulates the underlying...
01:29Bone Disorders
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...